Sex Differences in People Aging With HIV.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 03 2020
Historique:
entrez: 8 2 2020
pubmed: 8 2 2020
medline: 15 9 2020
Statut: ppublish

Résumé

To evaluate differences between older women and men with HIV regarding HIV variables, comorbidity, physical function, and quality of life (QOL). The Modena HIV clinic. Prospective cohort study. Cross-sectional analysis. Patients >50 years were included, stratified by sex. We recorded sociodemographic data, comorbidities, variables related to HIV infection, frailty, data on body composition, physical function, physical activity, and QOL. We evaluated 1126 older adults with HIV, of which 284 (25.2%) were women. Median age was 55 (IQR 6) years. There were significant differences between women and men in the median current CD4 T-cell and the mean CD4/CD8 ratio. There were differences regarding alcohol consumption, cardiovascular (CV) disease, hypertension, diabetes mellitus, and renal failure. Sarcopenia and slower gait speed were found more prevalent among men, but without significant differences. Significant differences were found regarding lower extremity strength measured by the chair stand test and in the short physical performance battery score. Short physical performance battery <9 was detected for 11.1% women vs. 5.6% men (P = 0.002). EQ5D5L score was 0.87 in women vs. 0.89 in men (P = 0.002). In our cohort, older women represented one in 4 of the total patients. Despite the fact that women have better immunological recovery measured by CD4 T-cell count and CD4/CD8 ratio, and fewer CV disease and CV risk factors than men, their physical function and their QOL are worse. Therefore, older HIV-infected women have special characteristics, and the assessment of physical function in this group seems to be crucial.

Sections du résumé

BACKGROUND
To evaluate differences between older women and men with HIV regarding HIV variables, comorbidity, physical function, and quality of life (QOL).
SETTING
The Modena HIV clinic.
METHODS
Prospective cohort study. Cross-sectional analysis. Patients >50 years were included, stratified by sex. We recorded sociodemographic data, comorbidities, variables related to HIV infection, frailty, data on body composition, physical function, physical activity, and QOL.
RESULTS
We evaluated 1126 older adults with HIV, of which 284 (25.2%) were women. Median age was 55 (IQR 6) years. There were significant differences between women and men in the median current CD4 T-cell and the mean CD4/CD8 ratio. There were differences regarding alcohol consumption, cardiovascular (CV) disease, hypertension, diabetes mellitus, and renal failure. Sarcopenia and slower gait speed were found more prevalent among men, but without significant differences. Significant differences were found regarding lower extremity strength measured by the chair stand test and in the short physical performance battery score. Short physical performance battery <9 was detected for 11.1% women vs. 5.6% men (P = 0.002). EQ5D5L score was 0.87 in women vs. 0.89 in men (P = 0.002).
CONCLUSIONS
In our cohort, older women represented one in 4 of the total patients. Despite the fact that women have better immunological recovery measured by CD4 T-cell count and CD4/CD8 ratio, and fewer CV disease and CV risk factors than men, their physical function and their QOL are worse. Therefore, older HIV-infected women have special characteristics, and the assessment of physical function in this group seems to be crucial.

Identifiants

pubmed: 32032279
doi: 10.1097/QAI.0000000000002259
pii: 00126334-202003010-00014
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

284-291

Références

UNAIDS Data 2018. Available at: http://wwwunaidsorg/sites/default/files/media_asset/unaids-data-2018_enpdf. Accessed April 2019.
Malave S, Ramakrishna J, Heylen E, et al. Differences in testing, stigma, and perceived consequences of stigmatization among heterosexual men and women living with HIV in Bengaluru, India. AIDS care. 2014;26:396–403.
Vosvick M, Martin LA, Smith NG, et al. Gender differences in HIV-related coping and depression. AIDS Behav. 2010;14:390–400.
Giles ML, Zapata MC, Wright ST, et al. How do outcomes compare between women and men living with HIV in Australia? An observational study. Sex Health. 2016;13:155–161.
Maskew M, Brennan AT, Westreich D, et al. Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients. J Womens Health (Larchmt). 2013;22:113–120.
Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. Antivir Ther. 2015;20:21–28.
Ochieng-Ooko V, Ochieng D, Sidle JE, et al. Influence of gender on loss to follow-up in a large HIV treatment programme in western Kenya. Bull World Health Organ. 2010;88:681–688.
Giles ML, Achhra AC, Abraham AG, et al. Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2018;21:e25149.
Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15:810–818.
Guaraldi G, Brothers TD, Zona S, et al. A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity. AIDS. 2015;29:1633–1641.
Palella FJ, Cole SR, Chmiel JS, et al. Anthropometrics and examiner-reported body habitus abnormalities in the multicenter AIDS cohort study. Clin Infect Dis. 2004;38:903–907.
Newman AB, Kupelian V, Visser M, et al. Health ABC Study Investigators. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51:1602–1609.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: associ-ation with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85–M94.
Craig CL, Marshall AL, Sjostrom M, et al. International physical activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395.
Radloff LS. The CES-D scale: a selfreport depression scale for research in the general population. Appl Psychol Measur. 1977;1:385–401.
Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–1736.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146–M156.
Sánchez-Conde M, Díaz-Álvarez J, Dronda F, et al. Why are people with HIV considered “older adults” in their fifties? Eur Geriatr Med. 2019;10:183–188.
Menzaghi B, Ricci E, Vichi F, et al. Gender differences in HIV infection: is there a problem? Analysis from the SCOLTA cohorts. Biomed Pharmacother. 2014;68:385–390.
Bastard M, Soulinphumy K, Phimmasone P, et al. Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic. BMC Infect Dis. 2013;13:27.
Maman D, Pujades-Rodriguez M, Subtil F, et al. Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa. PLoS One. 2012;7:e31078.
Focà E, Magro P, Guaraldi G, et al. GEPPO (GEriatric patients living with HIV/AIDS: a prospective multidimensional cOhort) study group. Elderly HIV-positive women: a gender-based analysis from the multicenter Italian “GEPPO” cohort. PLoS One. 2019;14:e0222225.
Sainz T, Serrano-Villar S, Diaz L, et al. The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults. AIDS. 2013;27:1513–1516.
Serrano-Villar S, Moreno S, Fuentes-Ferrer M, et al. The CD4:CD8 ratio is associated with markers of age-associated disease in virally suppressed HIV-infected patients with immunological recovery. HIV Med. 2014;15:40–49.
Womack JA, Chang CC, So-Armah KA, et al. HIV infection and cardiovascular disease in women. J Am Heart Assoc. 2014;3:e001035.
Fantry LE, Zhan M, Taylor GH, et al. Age of menopause and menopausal symptoms in HIV-infected women. AIDS Patient care and STDs. 2005;19:703–711.
Triant VA, Lee H, Hadigan C, et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92:2506–2512.
Mary-Krause M, Cotte L, Simon A, et al. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS. 2003;17:2479–2486.
Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. New Engl J Med. 2003;349:1993–2003.
Lang S, Mary-Krause M, Cotte L, et al. Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population. AIDS. 2010;24:1228–1230.
Stone L, Looby SE, Zanni MV. Cardiovascular disease risk among women living with HIV in North America and Europe. Curr Opin HIV AIDS. 2017;12:585–593.
Volpe M, Uglietti A, Castagna A, et al. Cardiovascular disease in women with HIV-1 infection. Int J Cardiol. 2017;241:50–56.
Lazarus JV, Safreed-Harmon K, Barton SE, et al. Beyond viral suppression of HIV - the new quality of life frontier. BMC Med. 2016;14:94.
Guaraldi G, Milic J, Wu AW. What is the measure of success in HIV? The fourth 90: quality of life or healthy aging? Eur Geriatr Med. 2019;10:267–274.
Hall KS, Cohen HJ, Pieper CF, et al. Physical performance across the adult life span: correlates with age and physical activity. J Gerontol A Biol Sci Med Sci. 2017;72:572–578.
Gardner AW, Montgomery PS. Differences in exercise performance and leisure-time physical activity in older men and women. Clin Med Geriatr. 2008;2008:9–15.
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43:748–759.
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age ageing. 2019;48:16–31.
Schaap LA, van Schoor NM, Lips P, et al. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study amsterdam. J Gerontol Ser A Biol Sci Med Sci. 2018;73:1199–1204.
Steffl M, Bohannon RW, Sontakova L, et al. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging. 2017;12:835–845.
Tran T, Guardigni V, Pencina KM, et al. Atypical skeletal muscle profiles in human immunodeficiency virus-infected asymptomatic middle-aged adults. Clin Infect Dis. 2018;66:1918–1927.
Greene M, Covinsky K, Astemborski J, et al. The relationship of physical performance with HIV disease and mortality. AIDS. 2014;28:2711–2719.
Erlandson KM, Allshouse AA, Jankowski CM, et al. Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. HIV Clin Trials. 2012;13:324–334.
Brañas F, Jiménez Z, Sánchez-Conde M, et al. Frailty and physical function in older HIV-infected adults. Age Ageing. 2017;14:1–5.
Wall BT, van Loon LJ. Nutritional strategies to attenuate muscle disuse atrophy. Nutr Rev. 2013;71:195–208.
Miles MP, Heil DP, Larson KR, et al. Prior resistance training and sex influence muscle responses to arm suspension. Med Sci Sports Exerc. 2005;37:1983–1989.
Yasuda N, Glover EI, Phillips SM, et al. Sex-based differences in skeletal muscle function and morphology with short-term limb immobilization. J Appl Physiol. 2005;99:1085–1092.
Yarasheski KE, Scherzer R, Kotler DP, et al. Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol Ser A Biol Sci Med Sci. 2011;66:332–340.
Jones TE, Stephenson KW, King JG, et al. Sarcopenia—mechanisms and treatments. J Geriatr Phys Ther. 2009;32:83–89.
Hunter GR, McCarthy JP, Bamman MM. Effects of resistance training on older adults. Sports Med. 2004;34:329–348.
Paes Lda S, Borges JP, Dos Santos FM, et al. Effects of a 2-year supervised exercise program upon the body composition and muscular performance of HIV-infected patients. Open AIDS J. 2015;9:80–88.
Erlandson KM, MaWhinney S, Wilson M, et al. Physical function improvements with moderate or high-intensity exercise among older adults with or without HIV infection. AIDS. 2018;32:2317–2326.
O'Brien KK, Tynan AM, Nixon SA, et al. Effectiveness of Progressive Resistive Exercise (PRE) in the context of HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol. BMC Infect Dis. 2017;17:268.
Vancampfort D, Mugisha J, De Hert M, et al. Global physical activity levels among people living with HIV: a systematic review and meta-analysis. Disabil Rehabil. 2018;40:388–397.
Fekete EM, Williams SL, Skinta MD, et al. Gender differences in disclosure concerns and HIV-related quality of life. AIDS Care. 2016;28:450–454.
Mrus JM, Williams PL, Tsevat J, et al. Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res. 2005;14:479–491.
Garfin DR, Shin SS, Ekstrand ML, et al. Depression, social support, and stigma as predictors of quality of life over time: results from an Asha-based HIV/AIDS intervention in India. AIDS Care. 2019;31:563–571.
Campsmith ML, Nakashima AK, Davidson AJ. Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview project. Health Qual Life Outcomes. 2003;1:12.
Zeluf-Andersson G, Eriksson LE, Schonnesson LN, et al. Beyond viral suppression: the quality of life of people living with HIV in Sweden. AIDS Care. 2019;31:403–412.
Krashin DL, Merrill JO, Trescot AM. Opioids in the management of HIV-related pain. Pain Physician. 2012;15(3 suppl):ES157–ES168.
Tsao JC, Plankey MW, Young MA. Pain, psychological symptoms and prescription drug misuse in HIV: a literature review. J Pain Manag. 2012;5:111–118.
Brandt CP, Zvolensky MJ, Daumas SD, et al. Pain-related anxiety in relation to anxiety and depression among persons living with HIV/AIDS. AIDS Care. 2016;28:432–435.
Brañas F, Guaraldi G, Sánchez-Conde M. HIV and aging: time to bridge the gap between clinical research and clinical care. Eur Geriatr Med. 2019;10:165–167.

Auteurs

Fátima Brañas (F)

Geriatrics Department, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain.

Matilde Sánchez-Conde (M)

Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain; and.

Federica Carli (F)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Marianna Menozzi (M)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Alessandro Raimondi (A)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Jovana Milic (J)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Jacopo Franconi (J)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Gianluca Cuomo (G)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Cristina Mussini (C)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Santiago Moreno (S)

Infectious Diseases Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain; and.

Giovanni Guaraldi (G)

Infectious Diseases Unit, Modena HIV Metabolic Clinic, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH